Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 15/20 | 0.40 |
| ▸ | ITGAV | P06756 | 15/20 | 0.40 |
| ▸ | ITGA2B | P08514 | 14/20 | 0.40 |
| ▸ | PDE2A | O00408 | 1/20 | 0.35 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.35 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.35 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.35 |
| ▸ | PYGL | P06737 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9056960 | 0.99 | ITGB3 (0.40) | ITGB3ITGAVITGA2BPDE2APDE3B | |
| SCHEMBL9056228 | 0.99 | ITGB3 (0.41) | ITGB3ITGAVITGA2BPDE2APDE3B | |
| SCHEMBL9055221 | 0.92 | ITGB3 (0.43) | ITGB3ITGAVITGA2B | |
| SCHEMBL9055218 | 0.92 | ITGB3 (0.43) | ITGB3ITGAVITGA2B | |
| SCHEMBL9055303 | 0.89 | ITGB3 (0.44) | ITGB3ITGAVITGA2B | |
| SCHEMBL9056911 | 0.89 | ITGB3 (0.41) | ITGB3ITGAVITGA2B | |
| SCHEMBL9054860 | 0.84 | ITGB3 (0.42) | ITGB3ITGAVITGA2B | |
| SCHEMBL9056601 | 0.84 | SLC16A3 (0.34) | PDE2APDE3BPDE3AP2RY12ALDH1A1 | |
| SCHEMBL9058887 | 0.83 | F2 (0.48) | — | |
| SCHEMBL9058724 | 0.83 | F2 (0.49) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1996002517-A1 | SUBSTITUTED ARYLSULFONAMIDES, THEIR PREPARATION AND USE AS THROMBIN-INHIBITING MEDICAMENTS | DR. KARL THOMAE GMBH (DE) | 1996-02-01 | — | — | WO | disclosed |